Epehólyagrák kezelése. Epeúti és epehólyagrákban szenvedő betegek nem sebészi kezelése | Klinikai Onkológia

Irodalom 1.

Altemeier W. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: A casecontrol study. Hepatology, ; Benoist S. Bhuiya M. Clinicopathologic studies on perineural invasion of bile duct carcinoma.

Kónya Judit, családorvos Az epehólyag-daganat nem túl gyakori betegség.

Bismuth H. Obstet6. Bloustein PA. Association of carcinoma with congenital cystic conditions of the liver and bile ducts.

Az epekő jelei, tünetei és epekő oldás epesavakkal!

Bond GG, et epehólyagrák kezelése. Liver and biliary tract cancer among chemical workers.

Bret PM, Reinhold C. Magnetic resonance cholangiopancreatography. Endoscopy, ; Castro MP et al Efficacy of epehólyagrák kezelése in the treatment of patients with gallbladder carcinoma: a case report.

Cancer 82, Cheng J. Cisplatin,epirubicin and fluorouracil for advanced biliary tract carcinoma.

epehólyagrák kezelése Proc Am Soc Clin Oncol a Donohue J. Stewart, M. Cancer, Ekbom A. Lancet ,42Eschelman D. Radiology Fong Y. Cancer Francanzani AL, Conte D, Fraquelli M, et al: Increased cancer risk in a cohort of patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.

Hepatology Gall F. World J. Surg Hejna M. Eur J of Cancer ,4:, Biliary stent occlusion.

Jackson, A. Jason CH. Jarnagin WR. Ruo L. Little SA.